16867-04-2Relevant articles and documents
DERMATOLOGICAL COMPOSITIONS AND METHODS
-
, (2008/06/13)
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
Treatment of neurodegenerative diseases
-
, (2008/06/13)
Disclosed are methods for increasing the differentiation of mammalian neuronal cells for purposes of treating neurodegenerative diseases or nerve damage by administration of various compounds including alcohols, diols and/or triols and their analogues.
Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway
-
, (2008/06/13)
Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.
Oxidation Reaction of 2- and 4-Hydroxypyridines
Ansari, M. Aslam
, p. 972 - 973 (2007/10/02)
Benzoyl peroxide reacts with 2-hydroxypyridine (I) in chloroform to give 3-benzoyloxy-2-hydroxypyridine (IIIa) and pyridine-2,3-dione (IV).However, with 4-hydroxypyridine (II) it gives 4,4',4''-trihydroxy-3,3',3''-terpyridyl (V) and trichloromethyl-4-hydroxypyridine (VI).The latter appears to have been formed by substitution in II with trichloromethyl radical produced from the interaction of benzoyl peroxide with chloroform.